InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by DeLucia David. Director active across 2 companies, notably FIBROGEN INC. In total, 5 disclosures have been logged. Activity tracked since 6 March 2025. The latest transaction was disclosed on 6 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
DeLucia David is a declarant linked to FIBROGEN INC and KYNTRA BIO, INC., where he is Chief Financial Officer. The record shows 5 filings in total, and the 5 sampled filings, between 2025-03-07 and 2026-06-09, show 0 in purchases and 0 in sales, with transactions described as tax withholding.